David Gill, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Myovant
    Topic:
    Prostate Cancer
    Date added:
    05/11/2023
    Date updated:
    05/11/2023
    Relationship end date:
    06/11/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Prostate Cancer
    Date added:
    05/11/2023
    Date updated:
    05/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eisai
    Topic:
    Kidney Cancer
    Date added:
    05/11/2023
    Date updated:
    05/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Prostate Cancer
    Date added:
    05/11/2023
    Date updated:
    05/11/2023
Return to Salt Lake City Precision Oncology Symposium